Related Experiment Video
Updated: Jul 25, 2026
08:49
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Erotomania induced by venlafaxine: a case study
Acta Psychiatrica Scandinavica
|March 29, 2003
Summary
High doses of venlafaxine can induce erotomania, a rare condition. Lowering the venlafaxine dose resolved the symptoms, suggesting a link between antidepressants and the dopaminergic system.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Antidepressants, particularly venlafaxine, are widely prescribed for mood disorders.
- The dopaminergic system plays a crucial role in mood regulation and reward pathways.
- Iatrogenic psychiatric conditions associated with antidepressant use require careful monitoring.
Observation:
- A case study detailing the occurrence of erotomania in a patient treated with venlafaxine.
- Erotomania manifested on two separate occasions during high-dose venlafaxine therapy.
- Symptom resolution was observed upon dose reduction of venlafaxine.
Findings:
- Venlafaxine, at high doses, may precipitate erotomania.
- The temporal relationship suggests a causal link between venlafaxine dosage and erotomanic episodes.
- Antidepressant-induced alterations in dopaminergic neurotransmission are implicated.
Implications:
- Clinicians should be aware of the potential for erotomania as a rare side effect of venlafaxine.
- This case highlights the complex interplay between antidepressants and the dopaminergic system.
- Further research into mood-regulating neurotransmitters may inform the development of novel antidepressant therapies.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:27Panic Disorder
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...